Masakazu Tokura, President PLAY LIST from the beginning Current Priority Management Issues and Business Strategy Contents Performance Trends FY2017 vs. FY2016 FY2017 Core Operating Income by Sector vs. FY2016 FY2018 Forecast vs. FY2017 FY2018 Core Operating Income Forecast vs. FY2017 @6 FY2018 Core Operating Income by Sector vs. FY2017 Dividend Policy Progress on Corporate Business Plan (Overall) Corporate Business Plan: Basic Policy FY2018 Forecast vs. FY2018 Target FY2018 Core Operating Income by Sector vs. FY2018 Target Corporate Business Plan: Medium- to Long-term vs. FY2018 Performance Targets Capital Expenditure and Investment Forecast for FY2016-FY2018 (decision-making basis) Capital Expenditure and Investment Plan for FY2016-FY2018 (decision-making basis) Major Investments and Commercialization Schedule (Overall) Current Business Portfolio for FY2016-FY2018 @8 Progress on Corporate Business Plan (by Sector) Petrochemicals & Plastics: Challenges and Business Strategy Petrochemicals & Plastics: Progress on Strategic Initiatives Petrochemicals & Plastics: Rabigh Phase I Project Petrochemicals & Plastics: Rabigh Phase II Project Petrochemicals & Plastics: Enhancing the Licensing Business Petrochemicals & Plastics: MMA Monomer Energy & Functional Materials: Challenges and Business Strategy Energy & Functional Materials: Progress on Strategic Initiatives Energy & Functional Materials: Major Investment and Development Projects and Commercialization Schedule Energy & Functional Materials: Initiatives for Enhancing Heat-Resistant Separators Business Energy & Functional Materials: Growing Demand for PES IT-Related Chemicals: Challenges and Business Strategy IT-Related Chemicals: Progress on Strategic Initiatives IT-Related Chemicals: Major Investment Projects and Commercialization Schedule IT-Related Chemicals: Major Development Projects and Commercialization Schedule IT-Related Chemicals: OLED Panel Market and Sumitomo Chemical’s Products IT-Related Chemicals: Commercialization of Polymer OLED Materials @35 IT-Related Chemicals: Restructuring the Polarizing Film Business Health & Crop Sciences: Challenges and Business Strategy Health & Crop Sciences: Progress on Strategic Initiatives Health & Crop Sciences: Major Investments and Commercialization Schedule Health & Crop Sciences: Major Investments and Commercialization Schedule Health & Crop Sciences: Expanding Alliance with Major Agrochemical Producers Outside Japan Health & Crop Sciences: Expanding R&D Facilities and Test Fields Health & Crop Sciences: New Methionine Plant Pharmaceuticals: Challenges and Business Strategy Pharmaceuticals: Progress on Strategic Initiatives Pharmaceuticals: Major Investments and Commercialization Schedule Pharmaceuticals: Major Development Projects and Commercialization Schedule Pharmaceuticals: Regenerative Medicine and Cell Therapy Pharmaceuticals: Nihon Medi-Physics Expansion of Healthcare Businesses Initiatives for Maintaining Sustained Growth Collaboration with Startup Companies Digital Transformation Strengthening Governance SDGs Initiatives Commitment to Society External Evaluation What Sumitomo Chemical Strives To Be Cautionary Statement Back Next